Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Chaihu Jia Longgu Muli Decoction is a traditional Chinese medicine (TCM) formula derived from the classic "Chaihu Jia Longgu Muli Decoction" (Bupleurum plus Dragon Bone and Oyster Shell Decoction). It is being investigated as an adjunctive therapy for Parkinson's disease complicated by rapid eye movement sleep behavior disorder (RBD). The formula typically aims to soothe the liver, clear heat, and calm the spirit (Shen). In the context of Parkinson's disease, it is hypothesized to modulate the central nervous system, potentially influencing melatonin levels and improving both motor and non-motor symptoms like sleep disturbances. The "modified" version used by Huzhou Hospital of Traditional Chinese Medicine likely includes specific herbal adjustments tailored to the neurodegenerative and sleep-related pathology of Parkinson's patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Chaihu Jia Longgu Muli Decoction.